There has been an increased interest in donation after circulatory death (DCD) to expand donor pool for cardiac transplantation. Normothermic regional perfusion (NRP) allows in situ assessment of DCD hearts, allowing only acceptable organs to be procured. We sought to determine if extended cold storage was possible for DCD hearts following NRP and to compare hearts stored using standard cold storage with a novel cardioprotective solution designed for room temperature storage.
C
ardiac transplantation remains the gold-standard treatment for eligible patients with advanced heart failure 1 ; however, the number of suitable heart donors has plateaued while the number of adequate recipients continues to increase. 2, 3 Beating hearts from donation after neurological determination of death are a widely accepted standard for transplantation. Grafts retrievals from donation after circulatory death (DCD) has been proposed as an alternative to increase the donor organ pool 2 ; however, these organs are invariably submitted to a period of warm ischemia and may sustain irreversible damage. The need for an accepted assessment tool to evaluate these hearts is of paramount importance. In this setting, cold storage, the accepted technique for organ preservation for transplantation, does not allow differentiation of reversible from irreversible graft damage.
The preservation strategies for the explanted heart are primarily based on hyperkalemic arrest and hypothermic storage with impermeant containing solutions to prevent edema, reactive oxygen species generation and acidosis. 4 However, with these solutions, energy depletion and reperfusion injury remain a problem. Novel preservation solutions are continuously studied to offset these adverse effects. 4 ,5 SOM-TRN-001 (SOM; Somahlution, FL) is an experimental solution designed exclusively to meet the energy requirements of the cardiomyocytes and coronary endothelium and has been shown to improve myocardial recovery following preservation. [6] [7] [8] [9] [10] Furthermore, using an isolated organ perfusion system, it has been shown to preserve hearts for transplantation better when used at subnormothermic conditions (21°C), avoiding the extreme hypothermia traditionally used in organ preservation. [6] [7] [8] [9] Despite this elegant demonstration of the benefits of SOM, no full transplantation studies have been performed using this solution.
Ex situ heart perfusion (ESHP) platforms have been developed to limit ischemic periods and enable continuous metabolic monitoring of DCD hearts; however, a validated functional assessment method, capable of predicting cardiac performance post-transplant and determining if these hearts are usable, has yet to be established. 11, 12 Furthermore, this technology involves a high upfront cost without a guarantee that the donor organ will be suitable for transplantation following perfusion. Messer et al 2 proposed a novel protocol for DCD heart transplantation based on normothermic regional perfusion (NRP). This technique restores myocardial perfusion within the donor after exclusion of the cerebral circulation and allows functional assessment of the donor heart before procurement. 2 Current DCD hearts protocols do not allow a prolonged period of cold static storage, with these organs being immediately mounted onto an ESHP system for transport to the recipient. 2 This strategy is resource intensive and involves high costs and personnel requirements for transplant centers. In this study, we tested the hypothesis that a brief period of static storage following NRP can be incorporated into protocols for DCD heart transplantation. As such, we sought to determine the feasibility of incorporating a static storage preservation period following NRP for DCD heart transplantation in a preclinical model. Furthermore, we sought to compare early post-transplant outcomes of hearts preserved with the standard cold storage technique using histidinetryptophan-ketoglutarate (HTK) at 4°C, with hearts preserved using SOM designed to preserve the organ at room temperature (Table I in the Data Supplement) .
METHODS
The data, analytic methods, and study materials will be made available for purposes of reproducing the results or replicating the procedure on reasonable and direct request with the corresponding author by email. Experimental protocols were approved by the institutional animal care committee, and animals were treated following the Guide for the Care and Use of Laboratory Animals prepared by the Institute of Laboratory Animal Resources, National Research Council, 1996.
Donor Procedure

Anesthesia, Monitoring, and Baseline Measurements
Male Yorkshire pigs (40 kg, Caughell Farms, ON, Canada) were used to perform 17 orthotopic cardiac transplants. Premedication was undertaken with an intramuscular
WHAT IS NEW?
• Hearts donated after circulatory determination of death tolerated an extended period of cold ischemia using a standard preservation solution after being reconditioned by normothermic regional perfusion.
• The use of a novel cardioprotective preservation solution (SOM-TRN-001) for the static storage of donation after circulatory death hearts improved recovery of function and decreased inflammatory response and endothelial injury following reperfusion.
WHAT ARE THE CLINICAL IMPLICATIONS?
• Normothermic regional perfusion leads to rapid organ reperfusion and allows the transplant team to perform a complete cardiac assessment before organ procurement, ensuring only suitable hearts are procured for transplantation.
• This can eliminate the current obligation to use costly portable heart perfusion systems and allow more centers to adopt donation after circulatory death heart transplantation.
injection of midazolam (0.3 mg/kg) and ketamine (20 mg/kg). Anesthesia was induced using inhalational isoflurane (1%-3%) and maintained on the same concentration through an oral endotracheal tube. Intravenous rocuronium (0.6 mg/kg) was injected before intubation. After performing a median sternotomy, the heart and great vessels were exposed. An arterial line was inserted through the right common carotid artery, a central venous line was introduced into the left jugular vein, and a pulmonary artery catheter was inserted via the right jugular vein and directed into position beyond the pulmonary artery bifurcation. An umbilical tape was placed around the inferior vena cava, and a pressure-volume conductance catheter (Millar Instruments Inc, Houston, TX) was inserted into the left ventricle (LV) through a small apical ventriculotomy to permit continuous measurements of LV pressure-volume relations. Systemic anticoagulation was achieved with an intravenous injection of 30 000 U heparin. Baseline hemodynamic and contractility measurements were taken at this time as described below.
Beating-Heart Donation (Control Group)
After baseline functional evaluation, a purse-string suture was placed in the ascending aorta to permit placement of a cardioplegia cannula. We obtained arterial and mixed venous blood samples just before aortic cross-clamping for baseline metabolic assessment. After cross-clamping, 1.5 L of HTK was infused into the aortic root at 4°C to achieve a cardioplegic arrest. The donor heart was excised, placed in an organ bag containing HTK, and stored on ice (control group).
DCD and Normothermic Regional Perfusion
A standard extracorporeal membrane oxygenator circuit comprising of a membrane oxygenator, centrifugal pump, and heat exchanger was used for NRP. The circuit was primed with 500 mL of crystalloid solution, 50 mL of 8.4% sodium bicarbonate, 2 g of magnesium sulfate, and 1 mg/kg of lidocaine. Immediately before cessation of mechanical ventilation, propofol (1 mg/kg/min) and remifentanil (1 µg/kg per minute) infusions were started, ensuring adequate anesthesia. Mechanical ventilation was discontinued in the paralyzed and preheparinized animal resulting in asphyxiation and circulatory arrest. Asystole was determined as the loss of pulsatility and pulse pressure on the arterial waveform. After asystole, an additional 15-minute warm ischemic period was observed before the start of NRP. Functional warm ischemic time was defined as the time since systolic blood pressure went below 50 mm Hg to the onset of reperfusion. The supra-aortic vessels were ligated, respecting the ethical regulations described for clinical NRP. 2 Oxygenated normothermic blood was delivered into the ascending aorta targeting a mean arterial pressure above 50 mm Hg. Continuous infusions of dopamine (10 µg/kg per minute) and vasopressin (4 units/min) were initiated as per clinical protocols.
2 Ventricular arrhythmias were treated with internal defibrillation (20J). Hyperkalemia (K + >6 mmol/L) was treated with insulin-dextrose infusions. Acidosis was corrected with administration of 8.4% sodium bicarbonate. Reperfusion was maintained for 1 hour. Arterial and mixed venous blood samples were collected at 15 and 60 minutes of NRP.
After this period, NRP was weaned to allow the heart to support circulation independently. Weaning was considered successful if animals maintained a systolic blood pressure above 60 mm Hg for over 30 minutes following discontinuation of NRP. Repeat hemodynamic and contractility measurements were performed at this point and cardiac procurement was performed as described above. DCD hearts were randomly assigned to be arrested and stored in HTK at 4°C (HTK group) or SOM at 21°C (SOM group). SOM was supplemented with 20 mmol/L of K + as previously described to achieve an adequate arrest. 6 Organ flush and storage were performed with 1.5 L and 500 mL of solution, respectively.
Recipient Procedure
We performed orthotopic cardiac transplantations as previously described by our group. 13 In brief, animal preparation, monitorization, and initial exposure were performed as in the donor protocol. The superior and inferior vena cava were encircled with umbilical tapes. Systemic anticoagulation was achieved with an intravenous injection of 30 000 U heparin. Ascending aortic and bicaval cannulations were used to place the recipient on cardiopulmonary bypass (CPB). Flow rates were adjusted to maintain a mean arterial pressure above 50 mm Hg. Normothermia was maintained throughout CPB.
The donor heart was removed from storage and implanted with a standard biatrial anastomotic technique. On removal of the donor heart from storage, an initial 500 mL of hypothermic blood cardioplegia was infused into the aortic root. Cardioplegic protection consisted of 300 mL of a 2:1 mixture of blood/crystalloid and was delivered at 10°C after the completion of each anastomosis. Before removal of the aortic cross-clamp, an additional 500 mL of warm blood cardioplegia and 500 mg of methylprednisolone were administered to the donor heart and recipient, respectively.
After 60 minutes of reperfusion, 1 g calcium chloride was administered to all animals, and they were weaned from CPB. Weaning was deemed successful if the animals maintained a systolic arterial pressure of 60 mm Hg for 30 minutes after the discontinuation of CPB. A vasoactive infusion of dobutamine (5-10 µg/kg per minute) and epinephrine (0.1-0.2 µg/ kg per minute) was used at the investigators' discretion to assist in weaning from CPB, simulating the clinical scenario. The vasoactive-inotropic score was then calculated as previously described and compared between groups.
14 After a successful separation from CPB, the cardiac assessment was performed at 2 and 3 hours postreperfusion, and the experiment was terminated.
Assessment of Cardiac Function
Global function was evaluated by cardiac output measurements using the thermodilution technique. Cardiac index (CI) was then calculated as the ratio between cardiac output and body surface area. Right ventricular (RV) function was assessed using the RV stroke work index. LV function was assessed using a conductance catheter (Ventri-Cath-507S, Millar Inc, Houston, TX) calibrated according to the manufacturer's instructions to record pressure-volume loops and relationships using the IOX v1.8.9.13 software (EMKA Technologies Inc, Falls Church, VA). Evaluations were performed at baseline, after weaning from NRP, and at 2 and 3 hours after opening the aortic cross-clamp (post-transplant reperfusion).
Endothelial Functional Assessment
Endothelium-dependent (E dep ) and endothelium-independent (E ind ) vascular relaxation were assessed in vitro by constructing dose-response curves with a small-vessel myograph for isometric tension recording as previously described. 13 In brief, the left anterior descending (LAD) coronary artery was harvested at the end of each experiment, cleaned of connective tissue and placed into Krebs-Henseleit solution. Vessels were cut into 5 mm segments and suspended between 2 wires, one of which was connected to an isometric force transducer. Data were collected with AcqKnowledge software (Biopac Systems Inc). The rings were bathed at all times with Krebs solution at 37°C and oxygenated with a 95% oxygen/5% carbon dioxide mixture.
The tissue was stretched to 3 g and allowed to stabilize for 90 minutes. They were then precontracted with a thromboxane A2 analog, U46619 compound (30 nmol/L). E dep vasorelaxation was assessed using a dose response to bradykinin (0.25-1.0 nmol/L) and, similarly, E ind vasorelaxation was assessed using a dose response to sodium nitroprusside (SNP: 10 to 5 mmol/L). Sensitivity to vasospasm was assessed by incremental exposure to ET-1 (endothelin-1; 0.05-15 nmol/L). Two to 4 segments of LAD coronary artery were obtained from each heart, and the data were averaged for analysis.
Biochemical Analysis
Metabolism
Arterial and mixed venous blood samples were collected for measurements of pH, lactate levels, pO 2 , hemoglobin, hematocrit, and oxygen saturation using a point-of-care blood gas analyzer (RAPIDPoint 500 Blood Gas Systems, Siemens).
Endothelial Activation
Myocardial and LAD expression of ET A (endothelin A receptor), ET B (endothelin B receptor), and VCAM-1 (vascular cellular adhesion molecule 1) were detected by standard Western blot techniques using porcine specific monoclonal antibodies (Abcam, Cambridge, United Kingdom). ET A and ET B were used at a concentration of 1:5000 in a 5% skim milk solution, VCAM-1 was used at a concentration of 1:1000 in a 3% BSA solution. Secondary horseradish peroxidase-conjugated antibodies were used at a concentration between 1:10 000 (Cell Signaling Technology, Danvers, MA) with ECL Plus used as a substrate (GE Healthcare, United Kingdom). GAPDH was detected as a loading control for all blots.
Oxidative Stress
Myocardial and LAD 8-isoprostane levels were determined using an ELISA Kit (Cayman Chemical, Ann Arbor, MI) as per manufacturers instructions.
Tissue Injury and Apoptosis
Mid-LV free wall full thickness biopsies were taken at the end of the experiment for histological analysis. Myocardial levels of activated caspase-3 were also measured by western immunoblotting using a monoclonal antibody (Abcam, Cambridge, United Kingdom) at 1:1000 as described above.
Inflammatory Response
Cytokine release was assessed in venous plasma samples taken from the recipient at baseline and at 15 and 60 minutes of reperfusion. A commercial Millipore MILLIPLEX Porcine cytokine/chemokine array analyzed with a BioPlex 200 (Eve Technologies, Calgary, AB, Canada) was used to measure 13 target molecules (GM-CSF, IFN-γ, IL-1α, IL-1ra, IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12, IL-18, and TNF-α).
Statistical Analysis
Statistical analysis was performed using the SPSS statistical software (Version 24; IBM). Continuous data were expressed as mean±SD or median (interquartile range) where appropriate and were analyzed using Kruskal-Wallis or Generalized Estimated Equations with a Bonferroni post hoc test evaluating the main effects of group and time as well as the interactive effect (group-time), where appropriate (please see the Data Supplement for further details). Significance was set at α=0.05 for all statistical tests.
RESULTS
Protocol Feasibility
Of the 17 attempted transplants, 14 were successfully completed and weaned from CPB. Two cases were unable to wean from NRP because of irreversible contractile dysfunction and were not transplanted. One case required a cardioplegic arrest after reperfusion because of a pulmonary artery tear and was not capable of weaning from CPB.
The Table depicts the different time points between groups. Median functional warm ischemic time in the HTK and SOM groups was 20 and 21 minutes, respectively, and did not differ between them. Median NRP time was also similar between both groups (66 and 67 minutes, respectively). There were no differences in storage time or total ischemic time. After implantation, there were no differences in CPB times or vasoactive-inotropic scores among groups. Finally, no differences in post-transplantation systemic, pulmonary, central venous, or pulmonary capillary wedge pressures were observed between groups (Table II in the Data Supplement).
Cardiac Contractile Function: Control Versus HTK
No transplanted heart exhibited signs of hyperacute rejection such as cyanosis or coronary thrombosis. Figure 1 illustrates contractility values measured in donor animals at baseline and following NRP, and in recipients at 2 and 3 hours post-transplantation. HTK hearts demonstrated a nonsignificant decrease in CI from 4.8±1.5 to 3.7±1.7 following hypoxia and NRP reconditioning. A significant reduction was noted 2 and 3 hours post-transplantation (2.1±0.8 and 2.8±0.6, respectively; P<0.01) compared with baseline and NRP. Similarly, control hearts demonstrated a significant decline in CI following transplantation (baseline: 4.9±0.6, 3 hours: 2.4±0.5; P<0.001). However, there were no differences in between groups following transplantation (P=0.735).
Figure 1B through 1E and Table III in the Data Supplement illustrate LV contractile function. With the exception of stroke work ( Figure 1C ), the remaining parameters showed improvement compared with baseline in both control and HTK hearts. This may represent the LV contractile reserve in response to inotropic infusion. Figure 1F shows RV stroke work index, which significantly decreased in both groups 2 hours post-transplantation. HTK hearts, however, demonstrated significant recovery to baseline levels at 3 hours of reperfusion compared with the control group (P=0.011).
SOM Improves DCD Heart Preservation: HTK Versus SOM
After DCD induction and NRP reconditioning, we compared cardiac function between DCD hearts which were to be assigned to either HTK or SOM for static storage (Figure 2 ). Hearts that were assigned to be preserved with HTK demonstrated improved recovery of function following NRP compared with those hearts assigned to the SOM group. Up to this point, no specific intervention had been administered that should have enabled differentiation between groups.
Despite this contractile dysfunction following NRP, SOM solution significantly improved myocardial preservation as seen by the conserved CI this group showed during reperfusion (CI baseline 4.8±1.0, post-NRP 3.3±2.1, 2 hours post-transplantation 2.4±0.7, 3 hours post-transplantation 3.0±1.0 L/min per m 2 ; P=0.001; Figure 1A ). Similarly, stroke work and dP/dt max ( Figure 1C and 1D ) also showed that SOM improved preservation of systolic function compared with HTK following static storage. There were no significant changes in PRSW compared with NRP in either group. SOM solution improved preservation of diastolic function, as seen by the improvement in dP/dt min and a stable τ following transplantation ( Figure 1D and  1E) . Furthermore, SOM hearts demonstrated better relative diastolic function at 2 and 3 hours of reperfusion compared with the HTK group. About RV function, preservation in HTK led to an initial decrease in RV stroke work index followed by recovery to similar levels as NRP ( Figure 1F ). SOM improved preservation of RV function following transplantation ( Figure 1F) . Again, this increase may represent the effect of inotropic support and myocardial reserve. Figure 3A) . No difference was seen in sensitivity to SNP between groups (SNP ED 50 control 2.4×10 −7 , HTK 3.3×10 −7 , SOM 2.4×10 −7 mol/L; P=0.303; Figure 3B ). Finally, no difference was shown in maximum vasorelaxation to bradykinin (control 60±5%, HTK 67±2%, and SOM 65±6%; P=0.269) or SNP (control 75±1%, HTK 76±1%, and SOM 73±2%; P=0.188) between groups.
Coronary Vasomotor Function
Control hearts demonstrated increased sensitivity to ET-1 induced vasospasm compared with the HTK and SOM groups (ET-1 ED 50 control 2.9×10 −9 , HTK 6.7×10 −9 , and SOM 7.2×10 −9 mol/L; P=0.050; Figure 3C ). In addition, controls presented with an altered Cmax compared with HTK and SOM hearts which was not statistically significant (Cmax control 205±46, HTK 125±27, and SOM 103±23% increase from baseline; P=0.131). 
Biochemical Parameters
Lactate Metabolism
As seen in Figure 4A , myocardial lactate release (measured in mixed venous samples) was not statistically different between groups at baseline (control 1.00±0. Oxidative Stress Levels of 8-isoprostane, a marker of lipid peroxidation, were measured in LV and LAD samples were taken at the end of the experiment ( Figure 4B and 4C). Although control hearts revealed higher levels of 8-isoprostane in both LV (control 31±1, HTK 12±0, and SOM 14±3; P=0.094) and LAD (control 99±17, HTK 41±14, and SOM 50±31; P=0.137) samples com- pared with HTK and SOM hearts, no significant differences were seen between groups. Figure 5A illustrates VCAM-1 levels measured in LAD biopsies; there were no differences between groups (control 8±4, HTK 3±0, and SOM 3±2×10 −2 arbitrary units of density; P=0.708). As seen in Figure 5 , there were no significant differences in ET A , ET B , or ET A /ET B ratio expression between groups (control 10±5, HTK 9±3, and SOM 4±2×10 arbitrary units of density; P=0.553; Figure 5D ).
Endothelial Activation
Tissue Injury and Apoptosis
Levels of activated caspase-3 were measured in LV biopsies taken at the end of the experiment. No difference was noted between groups (control 5±1, HTK 5±1, and SOM 6±1×10 −3 arbitrary units of density; P=0.708). On histological examination, most hearts appeared edematous and presented subendocardial areas of interstitial hemorrhage. Control hearts did not show marked evidence of ischemic damage, while DCD hearts from both hearts showed limited zones of injury demonstrated by the presence of contraction bands, vacuolized, or fragmented hypereosinophilic myofibers. DCD hearts preserved in HTK subjectively appeared to have greater polymorphonuclear infiltration ( Figure 6 ). Figure 7 illustrates the cytokine profiles in the recipients at baseline and at 15 and 60 minutes after opening the aortic cross-clamp (reperfusion). Across all groups, a similar and significant increase following reperfusion was noted in GM-CSF, IL-1β, IL-1ra, IL-6, IL-8, and TNF-α (data not shown) in all groups. Preservation with SOM led to a significantly decreased production of proinflammatory cytokines (IFN-γ, IL-1α, IL-2, IL-4, IL-12, and IL-18) compared with control and HTK hearts.
Inflammatory Response
DISCUSSION
In this study, we described a novel protocol for cardiac transplantation using hearts donated after circulatory death, resuscitated with NRP, and preserved for a clinically relevant extended period of static storage. We used A, Endothelial-dependent vasorelaxation. Histidine-tryptophan-ketoglutarate (HTK) hearts demonstrated an impaired relaxation pattern compared with controls; SOM tended to decrease this impairment. B, Endothelial-independent vasorelaxation. No differences were seen between groups. C, Sensitivity to ET-1 (endothelin-1). Control hearts showed a nonsignificant increase in sensitivity to ET-1; no differences were seen between HTK and SOM hearts. BK indicates bradykinin; and SNP, sodium nitroprusside.
a large-animal model of hypoxic cardiac arrest and compared the outcomes to standard beating-heart donation transplant protocols. Furthermore, we have reported the potential advantages of using SOM as a preservation solution in this setting, such as improved functional recovery following reperfusion, and decreased endothelial dysfunction compared to HTK in our DCD groups (Figure 8) .
Over 70 cases have been reported of successful DCD heart transplants worldwide. Four different techniques have been used: direct procurement and cold static storage transportation, 15 direct procurement and perfusion transportation, 16 NRP and machine perfusion for transportation, 2 and, more recently, a report was published describing a successful case of NRP followed by cold static storage. 17 Messer et al, 2 in 2016, described their initial experience with NRP. Although the concept of placing the donor on extracorporeal support was not new, 18 their group was the first to use this technique to reperfuse the thoracic organs for cardiac procurement. NRP not only allowed for rapid reperfusion but also enabled cardiac functional assessment in situ before procurement using conventional methods, such as echocardiography and cardiac output measurements with a pulmonary artery catheter. Furthermore, there is a potential for minimizing primary graft dysfunction as seen in their follow-up study. 3 Overall, their heart transplant activity increased by 45% since they started using NRP.
Limitations of ESHP
Despite the different procurement methods currently used for adult DCD heart transplantation, both direct procurement and perfusion transportation and NRPmachine perfusion for transportation require ex situ perfusion for organ preservation and transportation to the recipient hospital. With the increasing need to expand the donor organ pool, new platforms for ex situ perfusion have been developed and tested in preclinical settings. [19] [20] [21] The Transmedics organ care system is the only clinically available ESHP device. 11 This system has not only been applied in standard and extended-criteria neurological determination of death transplantation 22 but has also successfully allowed the use of hearts donated after circulatory death to once again become a reality. 2, 16 Nevertheless, this technique still has significant limitations. For example, optimal perfusate composition, perfusion temperature, and coronary perfusion pressure remain unknown. Answering such questions is of critical importance to minimize myocardial injury, decrease tissue edema, and allow for improved organ preservation during machine perfusion. 23, 24 Preclinical studies show that hearts present a time-dependent progressive functional decline despite improved results compared with cold static storage. 23 Furthermore, the organ care system relies solely on lactate metabolism to determine organ viability for transplantation. It is now known that this does not correlate well with early post-transplant outcomes and the development of primary graft failure. 24 Additionally, White et al, 12 in an elegant set of large animal experiments, have demonstrated the superiority contractility parameters have over metabolic ones in discriminating between hearts with adequate or reduced function. The optimal assessment tool, however, has yet to be determined.
Cold Storage Can Successfully Be Used for Hearts Donated After Circulatory Death
As these questions remain to be answered, it is crucial to seek other strategies to facilitate clinical incorpora- 9 tion of DCD heart transplantation. Previously, Ali et al 25 successfully described a preclinical DCD heart model resuscitated with CPB and transplanted following a period of cold storage. However, storage timing was not reported, only being mentioned that the recipient animal was concurrently prepared for implantation as the donor heart was excised. Nevertheless, this landmark article was the rationale behind the case recently described by Messer et al. 17 Here, they report one of their DCD heart transplantation cases where they successfully employed NRP followed by a 15-minute period of cold storage before implant. Of important note, the donor and recipient were collocated in this case. 17 What remained unanswered was if these DCD hearts could tolerate an extended period of cold ischemia to enable the use of this technique with distant procurement. In the present study, we successfully demonstrated the feasibility of such a protocol using a standard preservation solution. As seen in the Table, our timeline was in line with those described in the literature by the abovementioned groups currently performing clinical DCD heart transplantation. We kept DCD hearts for over 2 hours in cold storage in HTK, representing a feasible distant procurement protocol.
DCD induction followed by NRP decreased the donors' CI and RV function. However, we did not see reduction in measurements of isolated LV function. This has previously been described by Ali et al 25 and is secondary to both: the inotropic support used after weaning from NRP and to the catecholamine storm generated by during the hypoxic period. We think this represents the preservation of LV contractile reserve following the ischemic process. The RV is prone to ischemic injury and becomes significantly distended during the agonal and hypoxic phase, which may account for its functional decline along with the decrease in CI. Thus, the use of NRP for rapid resuscitation of our DCD hearts may have prevented significant irreversible damage to the myocardium. This is supported by our findings of limited ischemic damage in the DCD heart samples compared with controls. Additionally, following transplantation, DCD recipient animals were not only capable of successfully weaning from CPB but also demonstrated comparable left and right contractile function to controls. It is possible that through in situ reperfusion before organ procurement, NRP also activated postconditioning mechanisms which enabled cold storage in the DCD heart. The use of NRP permits for cardiac evaluation before procurement, allowing the transplant team to proceed with only suitable organs. It is important to note that, in our study, we did not exclude hearts based on functional assessment following NRP. Despite this fact, donor hearts demonstrated adequate functional recovery post-transplantation. More studies are needed to determine the relevance of functional parameters obtained in situ after NRP compared with current methods used during ESHP. However, from the successful cases described by the Papworth group, it seems to provide a reliable viability assessment.
SOM Improves Myocardial Preservation and Functional Recovery
As mentioned above, SOM is a novel experimental cardioprotective solution designed exclusively to meet the energy requirements of the cardiomyocytes and coronary endothelium. [6] [7] [8] [9] [10] Previous work by Lowalekar et al [6] [7] [8] [9] demonstrated, in experimental neurological determination of death and DCD heart models, improved functional recovery with the use of SOM during static storage when used at subnormothermic conditions (21°C). However, no full transplantation studies had been performed using this solution.
In our study, we showed that DCD heart transplantation using NRP for rapid resuscitation followed by cold static storage in a standard preservation solution instead of machine perfusion is feasible and safe. We then sought to investigate whether storing DCD hearts at room temperature in SOM could provide additional benefits over traditional hypothermic preservation. Interestingly, hearts assigned to be preserved with HTK demonstrated improved functional recovery following NRP compared with those hearts assigned to the SOM group. Up to this point, no specific intervention had been administered that should enable differentiation between groups as per the protocol described above.
Although SOM hearts demonstrated significantly reduced function following NRP compared with HTK hearts, organ flush and preservation at room temperature with SOM solution prevented functional degradation following transplantation. Additionally, we showed an improved LV and RV systolic function after reperfusion in hearts preserved with SOM compared with those stored in HTK. Finally, improved diastolic function was also seen in the SOM group compared with HTK.
Ischemia-reperfusion injury can affect the myocardium in several ways during organ procurement and transplantation. One of the main causes of contractile dysfunction during early reperfusion is the energy substrate depletion. SOM acts primarily by preventing depletion of ATP stores in the organ during the preservation period. 4, 8, 10 The improved contractility seen in our study supports these previous findings. However, more specific analyses on tissue injury and energy stores are still needed. Additionally, SOM is primed with components aimed towards increasing nitric oxide production and scavenging of reactive oxygen species. We analyzed the production and release of inflammatory cytokines following reperfusion. Inflammatory response was significantly decreased in the SOM compared with the HTK group, which could have also contributed to the improved hemodynamic profile seen in this group.
Of note, SOM hearts did require slightly more time on CPB and inotropic support following transplantation. Although these were not significantly different from HTK hearts, we think this was because of the more prominent functional decline some of the hearts assigned to SOM suffered following DCD induction before procurement and storage. Once again, to the best of our knowledge, this is the first study to use SOM as the preservation solution in a full heart transplantation model.
SOM Solution Improves Endothelial Function and Decreases Inflammatory Response
As abovementioned, SOM was designed to optimize cardiomyocyte and endothelial preservation by priming Figure 8 . A novel protocol for cardiac transplantation using hearts donated after circulatory death, resuscitated with normothermic regional perfusion, and preserved for an extended period of static storage. We used a large-animal model of hypoxic cardiac arrest and compared the outcomes to standard beating-heart donation transplant protocols. SOM has shown advantages as a preservation solution in this setting, with improved functional recovery following reperfusion, and decreased endothelial dysfunction compared with histidine-tryptophan-ketoglutarate (HTK) in our donation after circulatory death (DCD) groups. NRP indicates normothermic regional perfusion.
the organ with energy substrates, free radical scavengers, and postconditioning activators. 4, 26 Our group has previously described preliminary findings demonstrating the beneficial effects of SOM on the coronary endothelium. In a cell culture model, SOM decreased coronary endothelial activation and dysfunction following hypoxia/reoxygenation injury induced in vitro, leading to decreased leukocyte adhesion to the endothelium. 27 Furthermore, we demonstrated in an ex situ isolated heart perfusion model that SOM reduced reperfusion injury and coronary vasomotor dysfunction. 28, 29 In the present study, we directly evaluated coronary vasomotor function analyzing the dose response to bradykinin and SNP, representing endothelial-dependent and endothelial-independent vasorelaxation, respectively. Although no significant differences were seen between groups, we found that DCD heart allografts preserved in HTK demonstrated impaired endothelialdependent vasorelaxation response compared with control hearts. SOM, however, partially improved endothelial response, representing a potential protective effect compared with HTK within the DCD group. Interestingly, when we evaluated sensitivity to ET-1 induced vasospasm, control hearts demonstrated a greater response. This may represent an improved viability of these vessels; however, this may also be an artifact due to the inherent variability of the assessment and the limited sample size.
Overall, it is well known that the warm ischemic injury suffered by DCD allografts can potentially lead to decreased contractility and higher rates of primary graft failure. 3 However, whether this also leads to increased endothelial dysfunction remains unclear. Endothelial dysfunction is one of the hallmarks of transplantation injury, inducing no-reflow phenomenon and perpetuating the ischemic insult. This, in turn, leads to early allograft failure and later cardiac allograft vasculopathy. 30, 31 Longer follow-up in the current clinical DCD studies will determine if these allografts demonstrate higher rates of coronary vasculopathy.
After the post-transplantation inflammatory response, there was a significantly reduced production of proinflammatory cytokines during reperfusion in the SOM group. The activated endothelium releases proinflammatory cytokines, promoting the activation and binding of circulating leukocytes. Although we did not directly assess this issue in the present study, our group has previously demonstrated the protective effects against ischemia-reperfusion injury SOM exerts over the endothelium. 27, 29 Furthermore, DCD hearts preserved in HTK appeared to have a greater polymorphonuclear infiltration in LV samples, which corroborates with the inflammatory response. We think that improved strategies aimed at myocardial and endothelial protection during storage are the key to better outcomes in heart transplantation.
Limitations
This study has some important limitations worthy of note. As with most large animal preclinical studies, our sample size was small, and follow-up was limited to the early reperfusion period. Despite the limited sample size, our investigation was still able to provide relevant and consistent information on this novel protocol, having sufficient findings to suggest safety. The primary focus of our study was to determine the effects of this novel resuscitation and preservation protocol for DCD hearts. As such, initial reperfusion injury seems adequate to demonstrate the isolated effect of these factors, as longer-term follow-up studies include the effects of other confounding factors, such as rejection. Furthermore, a primary concern of NRP is with lung injury before procurement. Limited data exist on the effects of this technique of lung allografts. Our study was not designed to investigate the effects of NRP on donor lungs; however, no issues in donor ventilation and gas exchange were noted by the investigators following NRP (data not shown). This is an ongoing topic of study in our lab.
This study focused its assessment of clinically relevant functional outcomes and endothelial evaluations. We did not perform in-depth assessments related to tissue injury. We did, however, analyze 8-isoprostane, a marker of oxidative stress, as a surrogate of the reperfusion injury process and no differences were noted between groups. A direct assessment of myocardial levels of proinflammatory markers and energy stores is needed to investigate whether SOM also reduces tissue injury and is acting by preventing ATP depletion. However, we think that contractile parameters, such as those evaluated here, are of the utmost importance in these preclinical models. Further, they generate clinically relevant findings that can provide the direct translational potential of these interventions.
Conclusions
Current DCD heart transplantation strategies are resource intensive and involve high costs and personnel requirement for transplant centers. We demonstrated that DCD hearts could tolerate over 2 hours of cold ischemia after being reconditioned by NRP. This can eliminate the current obligation to use costly portable donor heart perfusion systems and allow more centers to adopt DCD heart transplantation. Additionally, NRP is already used to recondition other solid organs, such as livers and kidneys; although still under investigation, it could be used to facilitate DCD lung transplantation as well.
NRP leads to rapid organ reperfusion and allows the transplant team to perform a complete cardiac contractility assessment before organ procurement, ensuring only viable hearts are harvested. Our model-testing the hypothesis that transportation devices can be precluded in hearts donated after circulatory death-used conventional cardioplegia and cold storage and demonstrated similar early outcomes compared with conventional transplants using a beating-heart donation model. Furthermore, we demonstrated the potential benefits SOM solution could add to the preservation of DCD hearts, improving functional recovery and preventing endothelial dysfunction. As such, we believe short periods of cold storage, following successful NRP and documented adequate function, is an acceptable strategy for DCD hearts. Further testing is still needed to determine optimal parameters to predict cardiac performance following NRP and determine if more extended periods of storage are feasible.
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